Lyra Therapeutics - Lyra Therapeutics

We are pioneering a new therapeutic approach to treat debilitating ear, nose and throat (ENT) diseases that impact the lives of millions of people.

Lyra Therapeutics on LinkedIn: Events & Presentations

Lyra Therapeutics: Worthy Of A Small Bet (NASDAQ:LYRA)

Lyra Therapeutics - Lyra Therapeutics

Lyra Therapeutics First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags

Lyra Therapeutics (@LyraTx) / X

Lyra Therapeutics - Lyra Therapeutics

Lyra Therapeutics Appoints Jason Cavalier as Chief Financial Officer

Lyra's $100M private placement is music to the ears (and nose and throat)

Why Earnings Season Could Be Great for Lyra Therapeutics (LYRA)

Lyra Therapeutics: Worthy Of A Small Bet (NASDAQ:LYRA)

SEC Filing - Lyra Therapeutics, Inc.